@nagham.147: #نابلس #اكسبلورexplore #هيا_هيا_جايا_تصفار_وتخضار🤍 #هاشتاق #ترندات_تيك_توك

نَغٰمْ || nagham
نَغٰمْ || nagham
Open In TikTok:
Region: PS
Thursday 12 March 2026 19:02:04 GMT
143941
3216
22
665

Music

Download

Comments

farasha_.18
فــࢪاشهة :
لا شيئ يمر في حياتك عبثاً حتى عثراتك الصغيرة كانت لأجل أن تعرف شيئاً ما 🤍
2026-04-07 21:27:05
6
faiza.faiza4815
Leila Leila :
فعلا
2026-05-25 13:27:11
0
jnlnhnenn
شيخ الشباب :
يعني احنا ننتظر نعثر حتا نكون واعين خطأ مو صح لازم تكون واعي خلاص الكلام 👍
2026-05-13 17:26:55
0
wednesday3i3
𝑆𝑇𝐸𝐿𝐿𝐴 :
يمكن!
2026-05-19 19:04:19
0
user2329329816811
نيضام :
ربما
2026-05-14 22:41:50
0
ahmedtaha7123
الكردى :
يعنى عشان تتعلم لزم تغلط
2026-05-21 09:29:09
0
nagham.7n
《NAGHAM》♡♡ :
❤️❤️❤️
2026-03-12 19:43:38
2
l_667755
روز || 𝑹𝑶𝒁 💫🖤 :
🥺🥺
2026-03-12 22:09:52
1
nfkt5_
❤️‍🩹 :
💔💔💔
2026-03-12 22:52:15
1
user75473831244488
ابو ابراهيم 🌹💕🌹 :
🌹
2026-05-24 06:35:29
0
aa392514
آأيوشة aya 🌸🥰😌 :
😔😔
2026-05-23 23:34:12
0
hhh92060
hhh :
👍
2026-06-04 01:13:26
0
yaragal8
fatma_ik_fz :
❤️❤️❤️
2026-05-22 19:38:49
0
yoyoalsade313
يــويــو الـسـاعـدي🤍 :
❤️❤️❤️
2026-05-30 21:26:16
0
lasaadamich
Lasaad Amich :
🥰🥰🥰
2026-05-21 21:24:26
0
salahsemmadi
Salah Eddin :
👌
2026-05-21 11:38:28
0
mx_ml91
محمد السلماني :
🥺🥺🥺
2026-05-23 10:15:07
0
rana.abdo721
Rana Abdo :
😳😳😳
2026-05-17 05:48:37
0
h1122779
h1122779 :
❤️❤️❤️❤️❤️❤️
2026-05-14 18:57:58
0
awat.mhamad12
awat muhamd :
🥰🥰🥰🥰🥰🥰🥰
2026-05-14 03:57:24
0
lyanam97
LYANA-M :
🥰🥰🥰🥰
2026-05-23 11:01:00
0
To see more videos from user @nagham.147, please go to the Tikwm homepage.

Other Videos

Expand for Serious Side Effects incl. potential for blood to clot, and see profile for the HEMLIBRA full Prescribing Information and Medication Guide. Intended for US audiences only.  ------  What is HEMLIBRA?  HEMLIBRA is a prescription medicine used for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children, ages newborn and older, with hemophilia A with or without factor VIII inhibitors.  ------  What is the most important information I should know about HEMLIBRA?  HEMLIBRA increases the potential for your blood to clot. People who use activated prothrombin complex concentrate (aPCC; Feiba®) to treat breakthrough bleeds while taking HEMLIBRA may be at risk of serious side effects related to blood clots.  --  These serious side effects include:  • Thrombotic microangiopathy (TMA), a condition involving blood clots and injury to small blood vessels that may cause harm to your kidneys, brain, and other organs  • Blood clots (thrombotic events), which may form in blood vessels in your arm, leg, lung, or head  --  Carefully follow your healthcare provider’s instructions regarding when to use an on-demand bypassing agent or factor VIII, and the dose and schedule to use for breakthrough bleed treatment. If aPCC (Feiba®) is needed, talk to your healthcare provider in case you feel you need more than 100 U/kg of aPCC (Feiba®) total.  --  Your body may make antibodies against HEMLIBRA, which may stop HEMLIBRA from working properly. Contact your healthcare provider immediately if you notice that HEMLIBRA has stopped working for you (eg, increase in bleeds).  --  The most common side effects of HEMLIBRA include: injection site reactions (redness, tenderness, warmth, or itching at the site of injection), headache, and joint pain. These are not all of the possible side effects of HEMLIBRA. You can speak with your healthcare provider for more information.
Expand for Serious Side Effects incl. potential for blood to clot, and see profile for the HEMLIBRA full Prescribing Information and Medication Guide. Intended for US audiences only. ------ What is HEMLIBRA? HEMLIBRA is a prescription medicine used for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children, ages newborn and older, with hemophilia A with or without factor VIII inhibitors. ------ What is the most important information I should know about HEMLIBRA? HEMLIBRA increases the potential for your blood to clot. People who use activated prothrombin complex concentrate (aPCC; Feiba®) to treat breakthrough bleeds while taking HEMLIBRA may be at risk of serious side effects related to blood clots. -- These serious side effects include: • Thrombotic microangiopathy (TMA), a condition involving blood clots and injury to small blood vessels that may cause harm to your kidneys, brain, and other organs • Blood clots (thrombotic events), which may form in blood vessels in your arm, leg, lung, or head -- Carefully follow your healthcare provider’s instructions regarding when to use an on-demand bypassing agent or factor VIII, and the dose and schedule to use for breakthrough bleed treatment. If aPCC (Feiba®) is needed, talk to your healthcare provider in case you feel you need more than 100 U/kg of aPCC (Feiba®) total. -- Your body may make antibodies against HEMLIBRA, which may stop HEMLIBRA from working properly. Contact your healthcare provider immediately if you notice that HEMLIBRA has stopped working for you (eg, increase in bleeds). -- The most common side effects of HEMLIBRA include: injection site reactions (redness, tenderness, warmth, or itching at the site of injection), headache, and joint pain. These are not all of the possible side effects of HEMLIBRA. You can speak with your healthcare provider for more information.

About